Genprex, inc. (GNPX)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Sep'16
Revenues

-

-

-

-

-

-

-

-

0

0

0

0

0

0

Cost and expenses:
Depreciation

15

13

11

9

7

5

4

3

3

3

0

0

0

0

Research and development

2,936

1,967

1,794

1,816

1,427

971

715

281

273

289

0

0

0

0

General and administrative

11,135

8,702

9,892

9,688

12,411

11,386

8,864

7,817

2,970

3,019

0

0

0

0

Total costs and expenses

14,088

10,682

11,698

11,515

13,847

12,363

9,584

8,102

3,247

3,312

0

0

0

0

Operating loss

-14,088

-10,682

-11,698

-11,515

-13,847

-12,363

-9,584

-8,102

-3,247

-3,312

0

0

0

0

Interest income

25

27

38

44

41

29

16

5

0

0

0

0

0

0

Interest expense

-

-

-

-

-

37

39

39

9

1

0

0

0

-

Other expense

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Income tax expense

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net loss

-14,062

-10,654

-11,660

-11,471

-13,837

-12,372

-9,607

-8,136

-3,256

-3,314

0

0

0

0

Net loss per share—basic and diluted (in dollars per share)

-0.20

-0.13

-0.15

-0.24

-0.14

-0.24

-0.15

-0.45

-0.06

-0.06

-0.06

-0.10

-0.07

-2.25

Weighted average number of common shares— basic and diluted (in shares)

27,952

17,317

15,831

15,622

15,335

15,162

14,675

13,507

11,738

11,504

11,634

11,480

11,380

320